News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medivir AB (MVIRb.F) Appoints Luxembourg Pharmaceuticals Ltd. as Distributor for Xerclear(TM) in Israel and the Palestinean Authority



9/28/2010 11:25:39 AM

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Medivir AB (STO:MVIRB), the research-based speciality pharmaceutical company focused on infectious diseases, is today pleased to announce the appointment of Luxembourg Pharmaceuticals Ltd, as the exclusive distributor for Xerclear™, Medivir’s marketed and innovative treatment for recurrent cold sores, in Israel and the Palestinian Authority.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES